Related Experiment Video
Updated: Dec 23, 2025

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
[Cardiogenic Shock Complicating Myocardial Infarction]
Insights
Cardiogenic shock after myocardial infarction is deadly, but early revascularization improves survival. Mechanical circulatory support has not yet demonstrated benefits in randomized trials for these critical patients.
Area of Science:
- Cardiology
- Critical Care Medicine
Background:
- Cardiogenic shock (CS) is the leading cause of mortality in patients with acute myocardial infarction (AMI).
- Effective management requires multidisciplinary care within specialized centers and adherence to treatment guidelines.
Purpose of the Study:
- To review the critical management strategies for cardiogenic shock in acute myocardial infarction.
- To evaluate the role of early revascularization and mechanical circulatory support in improving patient outcomes.
Main Methods:
- Review of current literature and clinical guidelines on cardiogenic shock management.
- Analysis of treatment modalities including hemodynamic stabilization, early revascularization, and mechanical circulatory support.
Main Results:
- Initial management involves hemodynamic monitoring and stabilization with fluids, vasopressors, and inotropes.
- Early revascularization of the culprit lesion is the most crucial treatment for improving survival.
- Despite promising concepts, randomized trials have not shown improved short-term or long-term survival with mechanical circulatory support in infarct-related CS.
Conclusions:
- Guideline-compliant, multidisciplinary care is essential for patients with AMI-induced cardiogenic shock.
- Early revascularization is paramount, while the benefit of mechanical circulatory support requires further investigation.
Abstract:
In patients admitted with acute myocardial infarction, cardiogenic shock remains the most common cause of death. Multidisciplinary care in a specialized center and guideline-compliant treatment of cardiogenic shock are crucial for the survival and prognosis of affected patients. Hemodynamic monitoring and stabilization by volume expansion, vasopressors and inotropes represent initial steps in the management of patients with cardiogenic shock. Nevertheless, early revascularization of the culprit-lesion is proved to be the most important treatment modality. Although the use of active mechanical circulatory support appears to be a promising therapeutic concept to improve clinical outcome in patients with infarct-related cardiogenic shock, in the few previous randomized trials mechanical circulatory support failed to show beneficial effects on short-term and long-term survival.
Related Concept Videos
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Myocarditis I: Introduction
Acute Coronary Syndrome IV: Interprofessional Care
Introduction Cardiac Emergencies
Blood Pressure Imbalances and Circulatory Shock
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Cardiomyopathy III: Hypertrophic Cardiomyopathy

